Team Miro

Breaking new ground in immunology to help patients around the world

At MiroBio, we are driven to deliver transformational immunotherapies for people living with immune-mediated inflammatory disease, building on our unique expertise in checkpoint agonist antibody engineering.

Our Leadership

We are bringing together world-class expertise and drug development talent to make MiroBio an innovative force in immunology and turn our vision into a reality. We are united by the promise of an exciting new field and a thriving culture which celebrates scientific rigor, inclusivity, patient-first thinking and collaborative energy.

Carolin Barth, MD

Chief Executive Officer

lynne

Lynne Murray, PhD, MBA

SVP, Research and Development

MiroBio-Website-MP-092021-v02

Eliot Charles, PhD, MBA

Executive Chair

MiroBio-Website-SriniAkkaraju-092721-v02

Srinivas Akkaraju, MD, PhD

Director

Shahzad Malik, MD

Director

Debbie Harland, PhD, MBA

Director

MiroBio-Website-RichardCornall-092021-v02

Richard Cornall, MD, PhD, FMedSci

Co-founder, Scientific Advisor

simon_new_a-2

Simon Davis, PhD

Co-founder, Scientific Advisor

Jason G. Cyster, PhD

Tomas Mustelin, MD, PhD

Robert Stein, MD, PhD

Your browser is out-of-date!

Update your browser to view this website correctly. Outdated Browser

×